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Abstract: The success of an implant depends on the type of biomaterial used for its fabrication.
An ideal implant material should be biocompatible, inert, mechanically durable, and easily moldable.
The ability to build patient specific implants incorporated with bioactive drugs, cells, and proteins
has made 3D printing technology revolutionary in medical and pharmaceutical fields. A vast
variety of biomaterials are currently being used in medical 3D printing, including metals, ceramics,
polymers, and composites. With continuous research and progress in biomaterials used in 3D printing,
there has been a rapid growth in applications of 3D printing in manufacturing customized implants,
prostheses, drug delivery devices, and 3D scaffolds for tissue engineering and regenerative medicine.
The current review focuses on the novel biomaterials used in variety of 3D printing technologies
for clinical applications. Most common types of medical 3D printing technologies, including fused
deposition modeling, extrusion based bioprinting, inkjet, and polyjet printing techniques, their clinical
applications, different types of biomaterials currently used by researchers, and key limitations are
discussed in detail.
Keywords: additive manufacturing; 3D printing; biomaterials; customized implants; tissue engineering;
regenerative medicine; drug delivery; fused deposition modeling; bioprinting; inkjet; polyjet
1. Introduction
Three-dimensional printing is a process of building 3D objects from a digital file. In this process,
a digital 3D object is designed using computer aided design (CAD) software. SolidWorks, AutoCAD,
and ZBrush are some examples of popular CAD software used commercially in industries. Blender,
FreeCAD, Meshmixer, and SketchUp are some examples of the freeware commonly used to make 3D
models. These 3D objects are saved in a 3D printer-readable file format. The most common universal
file formats used for 3D printing are STL (stereolithography) and VRML (virtual reality modeling
language). Additive manufacturing file format (AMF), GCode, and ×3g are some of the other 3D
printer readable file formats. Figure 1 shows the steps involved in 3D printing of an object from
a CAD design.
In additive manufacturing, material is laid in layer-by-layer fashion in the required shape,
until the object is formed. Although the term 3D printing is used as a synonym for additive
manufacturing, there are several different fabricating processes involved in this technology. Depending
on the 3D printing process, additive manufacturing can be classified into four categories, including
extrusion printing, material sintering, material binding, and object lamination. Table 1 shows a broad
classification of the different types of 3D printing techniques and their working principles.
J. Funct. Biomater. 2018, 9, 17; doi:10.3390/jfb9010017 www.mdpi.com/journal/jfb
J. Funct. Biomater. 2018, 9, 17 2 of 16
J. Funct. Biomater. 2017, 8, x FOR PEER REVIEW  2 of 16 
 
 
Figure 1. Sequential steps involved in a 3D printing process. (A) Designed 3D computer aided design 
(CAD) model; (B) Stereolithography (STL) file of the model; (C) Slicing or 3D printing software; (D) 
3D printed object. 




Modeling (FDM) [1] 
A thermoplastic material is melted and laid on to the build platform in layer-by-
layer fashion, until the object is formed. 
Materials: acrylonitrile butadiene styrene (ABS), poly-lactic acid (PLA), nylon. 
Bioprinting [2] 
Biological materials are extruded through a nozzle under pressure to lay down 
materials in sequential layers till the scaffold is built. 
Materials: alginate, chitosan, gelatin, collagen, fibrin. 
Material Sintering 
Selective Laser 
Sintering (SLS) [3] 
A high-power laser beam fuses the powdered materials in layer-by-layer pattern 
to form an object. 
Materials: nylon, polyamide. 
Electron Beam 
Manufacturing (EBM) 
EBM is similar to SLS, except for high power electron beam is used to fuse the 
powdered particles. 
Materials: titanium, cobalt−chrome alloy. 
Stereolithography 
(SLA) [4] 
A UV laser beam selectively hardens the photo-polymer resin in layers.  





CLIP is similar to SLA, except for UV beam is passed through a transparent 
window at the bottom of the resin and build platform raises upwards holding 
the 3D printed object. 
Materials: photopolymers. 
Material Binding 
Binder Jetting/Inkjet [5] 
A liquid binding material is selectively dropped into the powder bed in 
alternative layers of powder–binding liquid–powder, until the final object is 
formed. 
Materials: starch or gypsum (powder bed) and water (binding agent) 
Polyjet 
Polyjet printing is similar to inkjet, but instead of binding agents, photopolymer 
liquid is sprayed in layers onto the build platform and is instantaneously cured 
using UV light. 




Layers of adhesive coated material are successively glued together and cut in 
required shapes using a laser. 
Materials: thin sheets of paper, polyvinyl caprolactam (PVC) plastic, or metal 
laminates 
The 3D printing technology has been in use more than three decades in the automobile and 
aeronautical industries. In the medical field, the use of this technology was limited only to 3D printing 
of anatomical models for educational training purposes. Only with the recent advancements in 
developing novel biodegradable materials has the use of 3D printing in medical and pharmaceutical 
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Figure 1. Sequential steps involved in a 3D printing process. (A) Designed 3D computer aided design
(CAD) model; (B) Stereolithography (STL) file of the model; (C) Slicing or 3D printing software;
(D) 3D printed object.
Table 1. Types of 3D printing technologies.
Process Principle
Extrusion Printing
Fused Deposition Modeling (FDM) [1]
A thermoplastic material is melted and laid on to the build
platform in layer-by-layer fashion, until the object is formed.
Materials: acrylonitrile butadiene styrene (ABS), poly-lactic
acid (PLA), nylon.
Bioprinting [2]
Biological materials are extruded through a nozzle under
pressure to lay down materials in sequential layers till the
scaffold is built.
Materials: alginate, chitosan, gelatin, collagen, fibrin.
Material Sintering
Selective Laser Sintering (SLS) [3]
A high-power laser beam fuses the powdered materials in
layer-by-layer pattern to for an object.
Materials: nylon, polyamide.
Electron Beam Manufacturing (EBM)
EBM is similar to SLS, except for high power electron beam is
used to fuse the powdered particles.
Materials: titanium, cobalt−chrome alloy.
Stereolithography (SLA) [4]
A UV laser beam selectively hardens the photo-polymer resin
in layers.
Each layer is solidified and built on top of next until the object
is forme .
Materials: photopolymers.
Continuous Liquid Interface Prod ction (CLIP) [3]
CLIP is similar to SLA, except for UV beam is passed through
a transparent window at the bottom of the resin and build




A liquid binding materia is sel ctively dropped into the
powder bed in alternative layers of powder–binding
liquid–powder, until the final object is formed.
Materials: starch or gypsum (powder bed) and water
(binding agent)
Polyjet
Polyjet printing is similar to inkjet, but instead of inding
ag nts, photopolymer liquid is sprayed in layers onto the build
platform and is instantaneously cured using UV light.
Materials: polypropylene, polystyrene, polyc rbonate.
Lamination
Laminated Object Manufacturing (LOM)
Layers of adhesive coated material are successively glued
together and cut in required shapes using a laser.
Materials: thin sheets of paper, polyvinyl caprolactam (PVC)
plastic, or metal laminates
The 3D printing technology has been in use more than three decades in the automobile and
aeronautical industries. In the medical field, the use of this technology was limited only to 3D printing
of anatomical models for educational training purposes. Only with the recent advancements in
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developing novel biodegradable materials has the use of 3D printing in medical and pharmaceutical
fields boomed. Today, additive manufacturing technology has wide applications in the clinical field
and is rapidly expanding. It has revolutionized the healthcare system by customizing implants and
prostheses, building biomedical models and surgical aids personalized to the patient, and bioprinting
tissues and living scaffolds for regenerative medicine. Table 2 shows the applications of 3D printing
technology in various sectors.
Table 2. Applications of 3D printing.
Sector Applications
Industry Jigs, fixtures, and end-use parts for aeronautical industry
Prototypes and spare parts for automotive industry
Medical
Surgical models for perioperative surgical preparations
Dental fixtures, bridges, and crowns
Customized patient specific implants and prostheses
Living tissue scaffolds for tissue engineering and regenerative medicine
Pharmaceutical
Customized implants for drug delivery
Tablets, capsules, and other patient specific dosages
Food Designing and 3D printing complex shaped cakes, cookies, candies, pizzas, and other desserts
Fashion Jewelry, clothes, shoes, and other accessories
Household Plates, cups, spoons, holders, and other common household objects
Miscellaneous
Space: building prototypes and parts in space
Chemical industry: fabricating complex molecules and compounds
Construction: scale models with intricate architectures
Biomaterials are natural or synthetic substances that are in contact with biological systems,
and help to repair, replace, or augment any tissue or organ of the body for any period of time.
Based on the chemical nature of the substances, biomaterials used in 3D printing are broadly classified
into four categories, as show in Table 3. An ideal 3D printing biomaterial should be biocompatible,
easily printable with tunable degradation rates, and morphologically mimic living tissue.
Table 3. Biomaterials classification with their advantages, disadvantages, and applications.
Type Advantages Disadvantages Applications
Metals and metal alloys * High material strength * Corrosive
* Orthopedic implants,
screws, pins, and platesE.g.,: gold, platinum, titanium, steel,
chromium, cobalt
* Easy to fabricate and sterilize
* Aseptic loosening
* Excessive elastic modulus
Ceramics and carbon compounds * High material strength * Difficult to mold
* Bioactive orthopedic
implants
E.g.,: calcium phosphate salts (HA), glass,
oxides of aluminum and titanium
* Biocompatibility
* Excessive elastic modulus
* Dental implants
* Corrosion resistance * Artificial hearing aids
Polymers
* Biodegradable * Leachable in body fluids * Orthopedic and dentalimplants
* Biocompatible
* Hard to sterilize
* Prostheses
* Easily moldable and readily available * Tissue engineeringscaffolds
E.g.,: PMMA*, Polycaprolactone(PCL), PLA,
polycarbonates, polyurethanes
* Suitable mechanical strength * Drug delivery systems
Composites * Excellent mechanical properties * Expensive * Porous orthopedicimplants
E.g.,: Dental filling composites, carbon fiber
reinforced methyl methacrylate bone cement +
ultra-high molecular weight polyethylene
* Corrosive resistant * Laborious manufacturing
methods
* Dental fillings
* Rubber catheters and
gloves
* PMMA—poly (methyl methacrylate).
The selection of biomaterial for a 3D printing mechanism depends on the application of
end product. For instance, biomaterial used for orthopedic or dental applications should have
high mechanical stiffness and prolonged biodegradation rates. By contrast, for dermal or other
visceral organ applications, the biomaterial used should be flexible and have faster degradation
rates. The majority of biomaterials used in current medical 3D printing technology, such as metals,
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ceramics, hard polymers, and composites, are stiff, and thus widely used for orthodontic applications.
Soft polymers, including hydrogels, are widely used in bioprinting cells for tissue/organ fabrication.
The hydrogel microenvironment mimics the extracellular matrix of a living tissue, and thus, cells are
easily accommodated.
2. Commonly Used 3D Printing Technologies in the Medical Field
Among the various types of 3D printing techniques described in the Table 1, FDM, extrusion
based bioprinting, inkjet, and polyjet are the most common types of additive manufacturing techniques
used in the medical field.
2.1. Fused Deposition Modeling (FDM) or Free Form Fabriction (FFF)
FDM is the most common and inexpensive type of additive manufacturing technology. In this
technique, a thermoplastic filament is passed through a heated print head and is laid down on to the
build platform in layer-by-layer fashion, until the required object is formed. MakerBot, Ultimaker,
Flashforge, and Prusa are some of the commercially available inexpensive desktop 3D printers.
These printers are limited by the variety of the materials being used, and produce lower resolution
objects. Expensive FDM printers, which can use wide varieties of materials and can print at higher
resolutions are also available, such as Stratasys 3D printers. FDM printers can accommodate more
than one print head, and thus, can print multiple types of materials at a time. Usually, among these
multi-head printers, one of the print head bears a supporting filament which can be easily removed or
dissolved in water. Figure 2 shows the parts of FDM 3D printer.
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Figure 2. Dual head FDM 3D printer. (A) Building material; (B) Supporting material; (C) Print heads.
is the most common thermoplastic polymer used for FDM process. PLA, nylon, polycarbonate
(PC), and polyvinyl alcohol (PVA) are some of the th r commonly used printing filaments.
Lactic acid-b sed polymers, including PLA an PCL, are well known for their bioc mpatible and
i degrada l properties, and hence, are extensively used for medical and pharmaceutical applicatio s.
Additionally, PLA and PCL melt at low temperatures, 175 ◦C and 65 ◦C respectively, making it easy
to load drugs without losing their bioactivity d e to thermal degradation. These polymers undergo
hydrolysis in vivo, and are eliminated through excr tory pathways [6,7]. Comparatively, PCL has
lower mechanical strength than PLA, a d thus, used for on-load bearing applications.
Printi g parameters, such as raster angle, raster thickness, and layer height, play a crucial role in
fabricating biocompatible scaffolds with required pore size and mechanical strength. Combin tions
of materi ls, such as PCL/chitos n [8] or PCL/β-TCP (tricalcium phosphate) [9] are also used
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in the FDM process to enhance the bioactive properties of the scaffolds. FDM has the ability to
build constructs quickly, with dimensional accuracy and excellent mechanical properties. Hence it
is used widely for prototyping in industry. In medicine, FDM is used for fabricating customized
patient-specific medical devices, such as implants, prostheses, anatomical models, and surgical guides.
Various thermoplastic polymers are doped with variety of bioactive agents, including antibiotics [10],
chemotherapeutics [11], hormones [12], nanoparticles [13,14], and other oral dosages [15,16] for
personalized medicine. Using this technology, non-biocompatible materials, such as ABS [17] or
thermoplastic polyurethane (TPU), are used for creating medical models for perioperative surgical
planning and simulations [18]. These models are also used as a tool to explain the procedures to the
patients before they undergo surgery. Table 4 shows the types of biomaterials used in FDM technique
for clinical applications.
Table 4. Overview of the biomaterials used for FDM based 3D printing.
Materials Fabrication Process In Vivo/In Vitro Model Key Findings Ref.
Scaffolds for tissue engineering and regeneration
PCL + Chitosan
Porous PCL scaffolds were
3D printed at 130 ◦C,
print head speed of
1–3 mm/s and 1.5–3.0 bar
pressure. Thermosensitive
chitosan hydrogel was filled





3D printed scaffolds showed
greater cell retention and
proliferation of BMMSCs.
Stronger osteogenesis and higher
bone matrix formation shows




PCL melted at 110 ◦C and
β-TCP powder is added.
Membranes were 3D printed
at 110 ◦C and at 500 kPa.
Alveolar bone defects
on beagles
The 3D printed PCL/β-TCP
membranes showed enhanced
bone regeneration capabilities





Printing pressure 40–80 psi,
3 mm/s motor speed,
print head temperature
40 ± 5 ◦C, Cross-linked with
8% (w/v) NaOH in
70% ethanol.
Human monocytes
PLA based scaffolds increased the






with female sex hormones
(E1, E2, E3 and progesterone)
at 90 ◦C and 3D printed at









FDM can be used to fabricate
patient specific personalized
medicine for drug delivery.






PLA pellets coated with
gentamicin and
methotrexate were extruded
as filaments at 170 ◦C and
3D printed as beads and
catheters using Makerbot 3D




and E. coli (for antibiotics)
3D printed PLA constructs
successfully retained the
bioactivity. Clear demarcating
zones of inhibition was seen for
gentamicin constructs and
decrease in cell viability of
osteosarcoma cells proved the





doped with metal oxide
nanoparticles (TiO2, P25,
Cu2O, and MoO3)
Natural gum resins added
with 10% metal oxides were
extruded as filaments at
70–85 ◦C and 3D printed
into discs (10 mm × 5 mm)
at 80 ◦C while maintaining
the build platform
temperature at 60 ◦C and at






Naturally occurring polymers can
be successfully 3D printed.
Discs with just the resins
prevented only surface associated
microbial growth. Additionally,
metal oxide nanoparticles
increased the bacteriostatic effects
of the natural polymers
[13]
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Table 4. Cont.
Materials Fabrication Process In Vivo/In Vitro Model Key Findings Ref.
PVA
PVA filament was milled
and powdered. Paracetamol
and caffeine were added and
extruded as filaments at
180 ◦C. These filaments were
3D printing into tablets and
capsules at 200 ◦C with print
head speed of 150 mm/s
Novel oral dosage forms were
successfully fabricated. Capsules
with alternating layers of caffeine
and paracetamol were 3D printed.
[16]
Surgical guides and implants
ABS
CAD models were
developed using CT files of







The 3D printed models resembled
the CT data of the patients and
had an overall mean deviation of




powder was extruded into
filaments and 3D printed
into fistula stents,




A 45-year-old man was
implanted with this
tailor-made fistula implant
The 3D printed implant was




2.2. Extrusion Based Bioprinting
In this method, materials are extruded through a print head either by pneumatic pressure or
mechanical force. Similar to FDM, materials are continuously laid in layer-by-layer fashion until the
required shape is formed, as shown in Figure 3. Since this process does not involve any heating
procedures, it is most commonly used for fabricating tissue engineering constructs with cells and
growth hormones laden. Bioinks are the biomaterials laden with cells and other biological materials,
and used for 3D printing. This 3D printing process allows for the deposition of small units of cells
accurately, with minimal process-induced cell damage. Advantages such as precise deposition of cells,
control over the rate of cell distribution and process speed have greatly increased the applications of
this technology in fabricating living scaffolds.
A wide range of materials with varied viscosities and high cell density aggregates can be 3D
printed using this technique. A large variety of polymers are under research for the use in bioprinting
technology. Natural polymers, including collagen [20], gelatin [21], alginate [22], and hyaluronic acid
(HA) [23], and synthetic polymers, such as PVA [24] and polyethylene glycol (PEG), are commonly
used in bioinks for 3D printing. Often these bioinks are post-processed either by chemical or UV
crosslinking to enhance the constructs mechanical properties. Depending on the type of polymer
used in the bioink, biological tissues and scaffolds of varied complexity can be fabricated. Multiple
print heads carrying different types of cell lines for printing a complex multicellular construct can be
possible with this technique. Lee et al., have used six extrusion headed 3D printer with six different
bioinks, including PEG as a sacrificial ink to fabricate a living human ear [25]. Laronda et al., has used
this extrusion bioprinting to fabricate gelatin based ovarian implants which can accommodate ovarian
follicles. These implants restored the ovarian functions of the sterilized mice, and they even bore
offspring [21].
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Extrusion bioprinting has been used for fabricating scaffolds for regeneration of bone [26],
cartilage [22], aortic valve [27], skeletal muscle [28], neuronal [29], and other tissues. In spite of
all this success, material selection and mechanical strength still remains a major concern for bioprinting.
Fabricating vascularization within a complex tissue is still an unanswered problem faced by this
technology. To address this issue, researchers have focused on using sacrificial materials, which are
incorporated within the construct while 3D printing, and are removed in post-processing, leaving the
void spaces to act as vascularization channels [30]. Table 5 shows some of the biomaterials currently
used by researchers, and their applications.
Table 5. Biomaterials used for extrusion based bioprinting.
Materials Process In Vivo/In Vitro Model Key Findings Ref.
Gelatin (partially crosslinked)
The partially polymerized gel in the
print head was extruded at 30 ◦C
through a 100 µm diameter nozzle on
to a cooled platform (10 ◦C).
These were later crosslinked with
chemicals EDC/NHS * for thermal
and mechanical stability. Sterilization
was done by overnight incubation in













Using regenHU bioprinter, scaffolds
(4.8 mm× 4.8 mm× 1 mm) were
printed a p inting pressure 40 kPa
and 5 mm/s printing speed.
Crosslinked using CaCl2 for 10 min,







The cytotoxicity and cell
viability analysis proved




NFC + alginate; NFC + HA
RegenHu bioprinter was used to 3D
print the constructs of
7 mm × 7 mm × 1.2 mm dimensions
with the two bioinks loaded with
iPSCs. Printing spee was maintained
at 10–20 mm/s at 20–30 kPa printing
pressure. NFC-alginate constructs
were crosslinked with CaCl2 for 5 min
and NFC–HA constructs were




The iPSCs in NFC-alginate
constructs were
pluripotent for at least 5
weeks, and then formed
into hyaline like cartilage
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Table 5. Cont.
Materials Process In Vivo/In Vitro Model Key Findings Ref.
Methacrylated hyaluronic
acid (MeHA)
MeHA was dissolved in culture
medium along with photoinitiator
Irgacure 2959. Porous cubic
scaffolds were bioprinted using
Bioscaffolder dispensing system
3D bioprinter and scaffolds were










PVA and phytagel (1:1)
Printing was done at room
temperature with a print speed of
5 mm/s and flow rate of 6 mL/h
on to a cold build plate (−78.5 ◦C).
The scaffolds were stored at
−25 ◦C for 15 h. Constructs were
later coated with collagen,
poly-L-lysine or gelatin














(HA/β-TCP = 60:40) + HPMC
+ Polyethylenimine + ZrO2
Extruded at pressure of 600 kPa
and at printing speed of
100 mm/min. Samples were
sintered at 1100 ◦C
Tested on osteoblast like
sarcoma cells for cytotoxicity
and hMSCs for differentiation
potential of the scaffolds
Improved mechanical
properties of scaffolds





Calcium sulfate hydrate +
mesoporous bioglass + PCL
Extruded under pressure of
2.2–3.6 bar and speed of
4.5–8.2 mm/s
In vitro evaluation on hBMSc








+ Magnesium + PVA
Extruded using a 450 µm nozzle
and printed at speed of 6 mm/s.
Scaffolds were sintered at 1150 ◦C
In vitro testing on MC3T3








* EDC/NHS—(1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride)/N-hydroxysuccinimide;
HPMC—(hydroxypropyl methylcellulose); hMSCs—(human mesenchymal stem cells); hBMSc—(human bone
marrow stromal cells).
2.3. Material Sintering
In material sintering type of 3D printing technique, the powdered form of printing material in
a reservoir is fused into a solid object, either by using physical (UV/laser/electron beam) or chemical
(binding liquid) sources. SLA type is the oldest and widely used technology among metal sintering
3D printers. Unlike extrusion based printers, there is no contact between the print head and printing
object. The objects can be 3D printed with high accuracy and resolution with this technique. The major
limitation of this technology includes limited availability of photocurable polymer resins. Majority of
the SLA resins currently available are based on low molecular weight polyacrylate or epoxy resins.
For biomedical applications, polymer ceramic composite resins, made up of hydroxyapatite based
calcium phosphate salts, are commonly used.
2.4. Inkjet or Binder Jet Printing
This process is similar to SLS; instead of fusing the powder bed with laser or electron beam,
binding liquid is selectively dropped on to the powdered bed to bind the materials in a layer-by-layer
fashion as shown in Figure 4. This process is continued until the final object is formed. Thermal and
piezoelectric are two types of printing heads used in this technique. In thermal print head systems,
an electric heating unit is present inside the deposition head, which vaporizes the binding material to
form a vapor bubble. This vapor bubble expands due to pressure, and comes out of the print head as
a droplet. Whereas in the piezoelectric print head system, the voltage pulse in the print head induces
a volumetric change (changes in pressure and velocity) in the binder liquid, resulting in the formation
of a droplet. These printers are known for their precise deposition of the binder liquid with speed
and accuracy.
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ater, phosphoric acid, citric acid, PVA, poly-DL-lactide (PDLLA) are some of the commonly used
binding materials for inkjet 3D printing. A wide range of powdered substances, including polymers
and composites, are used for medical and tissue engineering applications. Finished 3D printed objects
are often post-processed to enhance the mechanical properties. Wang et al., have used phosphoric acid
and PVA as binding liquids to bind HA/β-TCP powders for bone tissue regeneration applications.
The accuracy and mechanical strength of constructs printed using phosphoric acid were higher than
constructs printed using PVA [35]. Sandler et al., have fabricated precise and personalized dosage forms
using concentrated solutions of paracetamol, theophylline, and caffeine [36]. Uddin et al., have surface
coated metallic transdermal needles with chemotherapeutic agents using Soluplus, a copolymer of
PVC–PVA–PEG, for transdermal drug delivery [37]. Table 6 shows the types of binding liquids and
respective powder materials used for inkjet printing.
Table 6. Bio aterials used for inkjet printing.
Materials Process In Vivo/In Vitro Model Key Findings Ref.
Powders: hydroxyapatite
+ β-T ); Binding liquid:
(0.6 wt % PVA + 0.25 wt %
Tween 80) and (8.75 wt %
phosphoric acid + 0.25 wt %
Tween 80)
Microporous cylindrical scaffolds
(3 mm × 10 mm) were 3D printed
using ZPrinter 250 printer at
0.1 mm powder thickness and
0.3 L/m3 binder spray velocity.





phosphoric acid showed better
fabrication accur cy and
mechanical properties than
constructs printed with PVA.
Both binding liquids showed
good cellular affinity with BMSCs.
[35]
Substrate: paper and polyethylene
terephthalate (PET); Binding
liquid: concentrated solution of
paracetamol, theophylline,
and caffeine
Concentrated drug solutions were
selectively placed on the
substrates at 30 ◦C, and at 10 µm




were successfully 3D printed
using inkjet technology.
The accurate deposition and
crystallization of the drugs can be
highly controlled. Precise and
personalized dosing of the drug
substances is possible with
this technology.
[36]
Powders: β-TCP + hydroxyapatite
+ dextrin; Binding liquid:
water + glycerol
Powder bed thickness was
maintained 100 µm at 0.006 m/s
print head speed. Constructs were
gradually heated up to 350 ◦C and
sintered at 1200 ◦C for 4 h.
Fibrin and BMP-2 were coated.
Osteoblasts were seeded on
the scaffolds.
Male Lewis rats
3D printed constructs with BMP-2
and osteoblast cells showed
enhanced ectopic bone formation.
[38]
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Table 6. Cont.
Materials Process In Vivo/In Vitro Model Key Findings Ref.
Powder: α-TCP; Binding liquid:
8.75 wt % phosphoric acid
+ 0.25 wt % Tween 80
Powder layer thickness 89 µm and
binder liquid to powder ratio 0.46.
Vancomycin and rifampin were
added to the powder bed.
Polylactic-co-glucolic acid (PLGA)
was coated in some groups.
Female BALB/cJ mice
Unlike PMMA, co-delivery of
drugs vancomycin and rifampin












cis-platin were added to the
polymer and jetted as fine
droplets (300 pL) on the needles at
1–5 m/s. Multiple coatings were
given to acquire desired
drug concentration.
Dermatomed porcine skin
Inkjet printing technology was









Miconazole in dimethyl sulfoxide
was sprayed at a rate of
10 pL/droplet of solution.
Drop spacing of 30 µm and 32.0 V




inkjet printing technology and
clear zone of inhibition was
demonstrated. Fabricated
constructs can be effectively used






89 µm layer height Osteoblast likesarcoma cells
Binder solution toxicity was
assayed by sintering specimens at
temperature ranging from
300–1100 ◦C. High temperature
sintered samples were compatible
[41]
Binding liquid: 8.75% phosphoric
acid + 0.25% Tween80 + 1%–2%
collagen; Substrate:
hydroxyapatite and α-TCP
89 µm layer height and binding





in vivo evaluation was
done on critical size
femoral defects on female
BLAB/cJ
Macroporosity up to 0.5 mm was
achieved. Incorporation of




Binding liquid: aqueous solution
of 2-pyrrolidone (zb63); Substrate:
calcium sulfate (plaster),
vinyl polymer and carbohydrate
Pore sizes of 0.4, 0.6, and 0.8 mm
were designed and printed at
binder to powder ratio of
0.24 (shell) and 0.12 (core)
Effect of layer thickness




Layer thickness of 0.1125 mm and
printing along X direction resulted




Binder liquid: mesoporous silica
nanoparticles, polyethyleneimine,
furosemide, and propylene glycol;
Substrate: hydroxypropyl methyl
cellulose (HPMC), and polyester
transparency films
Print speed at 200 mm/s,
resolution of 150 and 500 dpi,
and wet thickness of 500 µm






feasibility of printing drug loaded




Similar to inkjet printing, layers of photopolymer resin are jetted on to the build platform
and are simultaneously cured using UV light source, as shown in Figure 5. Unlike inkjet process,
multiple types of materials can be jetted simultaneously and cured. This gives us the ability to
fabricate a complex multi-material object. Due to these capabilities, polyjet is widely used in the
medical field to fabricate anatomical models for surgical planning and pre-operative simulations. High
resolution objects with varied modular strengths can be 3D printed with high dimensional accuracy
using polyjet technique. Since the UV source is right next to the jetting nozzle and cures the resin
instantaneously, post-processing of the construct will not be necessitated. This technology is relatively
new to the additive manufacturing field. Many types of photopolymers, such as ABS like, Veroclear,
Verodent, and Fullcure are commercially available for use in polyjet printing. Table 7 shows some of
the photopolymers used in medical applications.
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3D printed live size aortic
aneurysum phantom from
patients CT files using a Stratasys
Eden 260 polyjet printer.
The phantom cost was $254.49
and took 13 hours to 3D print.
Mock surgical procedure
was performed under live
fluoroscope using the 3D
printed phantom
Pre-surgical planning
& simulation was possible with
patient-specific abdominal aortic
aneurysm phantom. Simulation
was effective in planning surgical












The use of 3D printed intrahepatic
vessel models from patient’s data
(CT files) has greatly improved





3D printed customized surgical
aids (cutting and repositioning
guides) for genioplasty.
CAD/CAM models were created
from the patients CT images and
patient specific surgical guides
were fabricated using SLA based




3D printed genioplasty templates






resins on Connex 3 polyjet Printed at 16 µm layer height
3D printed anatomical
phantoms of liver and
microspheres from
patient’s CT data
These phantoms offered a method
to quantify radiation dose form






Printed anatomical liver with




for 3 cases of liver
transplant
6 patient specific liver models
were 3D printed (3 living donor
and 3 recipients). Significantly




resins printed using Objet
500 Connex
Printed anatomical model of head
with different materials for skin,
bone and tissues
Used these models as
a training tool for
neuro surgery
Significantly improved the






Printed with polymers that are





that can be imaged under CT and
MRI were developed. Improving





and Objet 350 Connex
Materials with different rigidity
were used to mimic native tissue’s
mechanical properties.




Aneurysm clippings and tumor
resection planning were efficiently






50 patients were randomly
chosen to explain medical
procedure using 3D
printed model
3D printed model of nasal sinus
anatomy was used as educational
tool to enable patients to make
informed decision. Results
suggest improved patient comfort
levels and outcomes.
[53]
Projet 3512 HD Rigid material was used to createmolds for nephrology sectioning.
5 patient specific slicing
guides were 3D printed for
partial nephrectomy
Enabled accurate sectioning of
tumors for colocalization
analysis for radiomic and
radiogenomic analyses
[54]
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2.6. Laminated Object Manufacturing
In this type of 3D printing technology, thin layers of paper, plastic, or metal sheets are glued
together in layer-by-layer fashion, and cut into the required shape using a metallic cutter or laser.
This process is inexpensive, fast, and easy to use. It fabricates relatively lower resolution objects and is
used for multicolor prototyping.
3. Limitations
Although 3D printing has the ability to fabricate on-demand, highly personalized complex
designs at low costs, this technology’s medical applications are limited due to lack of diversity in
biomaterials. Even with the availability of variety of biomaterials including metals, ceramics, polymers,
and composites, medical 3D printing is still confined by factors such as biomaterial printability, suitable
mechanical strength, biodegradation, and biocompatible properties.
Usually, in extrusion based bioprinting, higher concentrations of polymers are used in fabricating
bioinks to obtain structural integrity of the end product. This dense hydrogel environment limits
the cellular network and functional integration of the scaffold. For any moderate sized biological
scaffold to be functional, vascularization is of utmost importance, and is not possible with the current
3D printing technology. Small scale scaffolds currently printed in the laboratories of researchers can
easily survive through diffusion, but a life-size functional organ must have a profuse vascularization.
To address this problem, incorporation of sacrificial materials during the scaffold fabrication has been
used by many researchers. These materials fill up the void spaces, providing mechanical support to the
printing materials, and once constructs are fabricated, they are removed by post-processing methods.
Many sacrificial/fugitive materials including carbohydrate glass [55], pluronic glass [56], and gelatin
microparticles [57] are currently under investigation [5].
Additionally, design induced limitations cause material discontinuity, due to poor transformation
of complex CAD design into machine instructions. Process induced limitations include differences in
porosities of CAD object and finished 3D printed product [58].
4. Conclusions
In summary, 3D printing has been revolutionizing the medical field, and is still rapidly
expanding. Popular clinical applications include fabrication of patient-specific implants and prostheses;
engineering scaffolds for tissue regeneration and biosynthetic organs; personalization of drug delivery
systems; and anatomical modeling for perioperative simulations. The use of 3D printing in the medical
field is continuously growing, due to its capabilities, such as personalization of medicine, cost efficiency,
speed, and enhanced productivity [59]. With the advancement in 3D modeling software and mechanics
of the printing machine, the dimensional precision, speed, and tunability of a 3D printer has been
vastly improved. Using finite element analysis, the change in the mechanical properties of the finished
product with respect to printing parameters can be simulated, and best suiting parameters can be
obtained beforehand. Even with all these advancements, medical 3D printing is still budding and has
incredible potential.
Currently, there are only a limited number of biodegradable polymers available for 3D printing.
Most of these 3D printing biomaterials are used for either drug delivery or space-filling implantation
purposes. Therefore, there is a major need for research to fabricate novel biopolymers with tunable
bio-properties and that can restore functionality at the site of application. Inexpensive, readily available
lactic acid based polymers (such as PLA and PCL) are focused on, mainly due to their abilities to
perform well in most types of 3D printing technologies. Additionally, they have excellent mechanical
and biodegradable properties. These polymers are also mixed with traditional biomaterials (such as
HA, TCP) and used as composites to provide higher printability, mechanical stability, and greater
tissue integration for orthopedic applications.
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With continuous research in bioprinting and biomaterials technology, we are getting closer
to fabricating life-sized, fully functional 3D printed organs. Bioprinting is still in its early stages,
where many researchers have proved the feasibility of 3D printing a functional organ in a laboratory.
Soon, there will be an advancement in use of these biomaterials/bioinks from labs to clinical trials,
and eventually, in everyday clinical practice. This could be a potential solution to address the problem of
continuous organ donor’s shortage. Moreover, the ability of the 3D printer to fabricate tissues/organs
from the host cells will reduce the immune response of the implant, and in turn, reduce tissue rejection.
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